
Biosignals Diagnostics Pty Ltd is a health technology company focused on improving cardiovascular health through advanced monitoring and data analysis. Their primary product, ecgme™, is a credit-card sized device that enables users to perform various heart health checks, including arrhythmia and ischemia detection, and HRV evaluation. The system can be used for 30-second checks or extended 24-hour monitoring with an on-body adaptor. Users receive a cardiology report and have the option for a cardiologist review. The company aims to make cardiology more accurate by integrating biometric data with other sources like DNA, imaging, and genomics to better predict, diagnose, and treat cardiac diseases, particularly addressing diverse populations and gender differences. They are based in Australia and leverage technology such as AI and machine learning for data analysis.

Biosignals Diagnostics Pty Ltd is a health technology company focused on improving cardiovascular health through advanced monitoring and data analysis. Their primary product, ecgme™, is a credit-card sized device that enables users to perform various heart health checks, including arrhythmia and ischemia detection, and HRV evaluation. The system can be used for 30-second checks or extended 24-hour monitoring with an on-body adaptor. Users receive a cardiology report and have the option for a cardiologist review. The company aims to make cardiology more accurate by integrating biometric data with other sources like DNA, imaging, and genomics to better predict, diagnose, and treat cardiac diseases, particularly addressing diverse populations and gender differences. They are based in Australia and leverage technology such as AI and machine learning for data analysis.